July 26, 2021 Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes
July 15, 2021 Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy
July 13, 2021 Tau PET correlates with different Alzheimer’s disease-related features compared to CSF and plasma p-tau biomarkers
July 6, 2021 Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome
July 2, 2021 Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer’s disease in adults with Down syndrome
July 1, 2021 Evaluation of three commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2
June 29, 2021 Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Aβ-PET and cognition
June 21, 2021 Anti-interleukin-6 antibody clazakizumab in late antibody-mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism
June 16, 2021 Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2